Peregrine Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-478,109
| Closed | -$5.52M | – | 360 |
|
|
2020
Q4 | $5.52M | Sell |
478,109
-43,473
| -8% | -$502K | 0.1% | 252 |
|
|
2020
Q3 | $5.43M | Sell |
521,582
-49,606
| -9% | -$516K | 0.14% | 226 |
|
|
2020
Q2 | $7.51M | Sell |
571,188
-19,110
| -3% | -$251K | 0.21% | 148 |
|
|
2020
Q1 | $4.65M | Buy |
590,298
+1,930
| +0.3% | +$15.2K | 0.17% | 174 |
|
|
2019
Q4 | $12.2M | Sell |
588,368
-193,009
| -25% | -$4M | 0.31% | 131 |
|
|
2019
Q3 | $10.7M | Buy |
781,377
+25,603
| +3% | +$351K | 0.29% | 140 |
|
|
2019
Q2 | $9.3M | Sell |
755,774
-1,811
| -0.2% | -$22.3K | 0.23% | 167 |
|
|
2019
Q1 | $9.46M | Sell |
757,585
-15,460
| -2% | -$193K | 0.24% | 159 |
|
|
2018
Q4 | $8.75M | Sell |
773,045
-4,730
| -0.6% | -$53.5K | 0.25% | 149 |
|
|
2018
Q3 | $14.6M | Buy |
777,775
+111,615
| +17% | +$2.09M | 0.34% | 129 |
|
|
2018
Q2 | $17.2M | Buy |
666,160
+33,890
| +5% | +$876K | 0.43% | 106 |
|
|
2018
Q1 | $14.2M | Sell |
632,270
-30,605
| -5% | -$686K | 0.35% | 120 |
|
|
2017
Q4 | $16.6M | Buy |
662,875
+67,664
| +11% | +$1.69M | 0.39% | 106 |
|
|
2017
Q3 | $14.4M | Sell |
595,211
-114,052
| -16% | -$2.76M | 0.35% | 118 |
|
|
2017
Q2 | $14.3M | Sell |
709,263
-3,368
| -0.5% | -$68.1K | 0.36% | 109 |
|
|
2017
Q1 | $19.2M | Sell |
712,631
-24,256
| -3% | -$654K | 0.49% | 71 |
|
|
2016
Q4 | $14M | Buy |
736,887
+13,982
| +2% | +$266K | 0.36% | 111 |
|
|
2016
Q3 | $14.1M | Buy |
+722,905
| New | +$14.1M | 0.37% | 113 |
|